Altered protein profile of lymphocytes in an antigen-specific model of colitis: A comparative proteomic study

Inflammation Research

Volumn 56, Issue 9, 2007, Pages 377-384

  Liu, B G ^a   Cao, Y B ^a   Cao, Y Y ^a   Zhang, J D ^a   An, M M ^a   Wang, Y ^a   Gao, P H ^a   Yan, L ^a   Xu, Y ^a   Jiang, Y Y ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Colitis; Inflammatory bowel disease; Lymphocyte; Proteomics

Indexed keywords

ALCOHOL; CELL PROTEIN; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE REGULATION; CELL PROLIFERATION; COLITIS; COMPUTER PROGRAM; CONTROLLED STUDY; DOWN REGULATION; ENTERITIS; GENETIC TRANSCRIPTION; IMAGE ANALYSIS; INFLAMMATION; LYMPHOCYTE; MALE; MASS SPECTROMETRY; MESENTERY LYMPH NODE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN METABOLISM; PROTEOMICS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; VALIDATION PROCESS;

ANIMALS; APOPTOSIS; BLOOD PROTEINS; COLITIS; DISEASE MODELS, ANIMAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; OXIDATIVE STRESS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRINITROBENZENESULFONIC ACID;

EID: 34548840287     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-7035-0     Document Type: Article

References (38)

1. Nagaishi T, Iijima H, Nakajima A, Chen D, Blumberg RS. Role of CEACAM1 as a regulator of T cells. Ann NY Acad Sci 2006; 1072: 155-75.
2. Stokkers PC, Hommes DW. New cytokine therapeutics for inflammatory bowel disease. Cytokine 2004; 28: 167-73.
3. Ardizzone S, Bianchi Porro G. Biologic therapy for inflammatory bowel disease. Drugs 2005; 65: 2253-86.
4. Mizoguchi A, Mizoguchi E, Bhan AK. Immune networks in animal models of inflammatory bowel disease. Inflamm Bowel Dis 2003; 9: 246-59.
5. Fayad R, Brand MI, Stone D, Keshavarzian A, Qiao L. Apoptosis resistance in ulcerative colitis: high expression of decoy receptors by lamina propria T cells. Eur J Immunol 2006; 36: 2215-22.
6. Allenspach K, Bergman PJ, Sauter S, Grone A, Doherr MG, Gaschen F. P-glycoprotein expression in lamina propria lymphocytes of duodenal biopsy samples in dogs with chronic idiopathic enteropathies. J Comp Pathol 2006; 134: 1-7.
7. Weingarten P, Lutter P, Wattenberg A, Blueggel M, Bailey S, Klose J et al. Application of proteomics and protein analysis for biomarker and target finding for immunotherapy. Methods Mol Med 2005; 109: 155-74.
8. Khanna AK. Reciprocal role of cyclins and cyclin kinase inhibitor p21WAF1/CIP1 on lymphocyte proliferation, allo-immune activation and inflammation. BMC Immunol 2005; 6: 22.
9. Kok K, Stokkers P, Reitsma PH. Genomics and proteomics: implications for inflammatory bowel diseases. Inflamm Bowel Dis 2004; 10: 1-6.
10. Strober W, Ludviksson BR, Fuss U. The pathogenesis of mucosal inflammation in murine models of inflamatory bowel disease and Crohn disease. Ann Intern Med 1998; 128: 848-56.
11. Risso A, Tell G, Vascotto C, Costessi A, Arena S, Scaloni A et al. Activation of human T lymphocytes under conditions similar to those that occur during exposure to microgravity: a proteomics study. Proteomics 2005; 5: 1827-37.
12. Bliek JB, de Klein A, Luider TM, Lindemans J, Hulsman L, Guzel C et al. New approach for the identification of folate-related pathways in human embryogenesis. Cell Mol Biol 2004; 50: 939-44.
13. Stentz FB, Kitabchi AE. Transcriptome and proteome expression in activated human CD4 and CD8 T-lymphocytes. Biochem Biophys Res Commun 2004; 324: 692-96.
14. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
15. Barcelo-Batllori S, Andre M, Servis C, Levy N, Takikawa O, Michetti P et al. Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. Proteomics 2002; 2: 551-60.
16. Shiio Y, Suh KS, Lee H, Yuspa SH, Eisenman RN, Aebersold R. Quantitative proteomic analysis of chromatinassociatedfactors. J Am Soc Mass Spectrom 2003; 14: 696-703.
17. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68: 850-8.
18. Lopez MF, Berggren K, Chernokalskaya E, Lazarev A, Robinson M, Patton WF. A comparison of silver stain and SYPRO Ruby protein gel stain with respect to protein detection in two-dimensional gels and identification by peptide mass profiling Electrophoresis 2000; 21:3673-83.
19. Tonge R, Shaw J, Middleton B, Rowlinson R, Rayner S, Young J, Pognan F et al. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001; 1: 377-96.
20. Patton WF. Detection technologies in proteome analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 771: 3-31.
21. Yamamoto M, Torigoe T, Kamiguchi K, Hirohashi Y, Nakanishi K et al. A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis. Cancer Res 2005; 65: 8706-14.
22. Festjens N, Cornelis S, Lamkanfi M, Vandenabeele P. Caspase-containing complexes in the regulation of cell death and inflammation. Biol Chem 2006; 387: 1005-16.
23. Kohl A, Grutter MG. Fire and death: the pyrin domain joins the death-domain superfamily. C R Biol 2004; 327: 1077-86.
24. Reed JC, Doctor K, Rojas A, Zapata JM, Stehlik C, Fiorentino L et al. Comparative analysis of apoptosis and inflammation genes of mice and humans. Genome Res 2003; 13: 1376-88.
25. Shiohara M, Taniguchi S, Masumoto J, Yasui K, Koike K, Komiyama A et al. ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem Biophys Res Commun 2002; 293:1314-18.
26. Tanimoto Y, Kizaki H. Proteasome inhibitors block Ras/ERK signaling pathway resulting in the downregulation of Fas ligand expression during activation-induced cell death in T cells. J Biochem 2002; 131: 319-26.
27. Fuss IJ, Marth T, Neurath MF, Pearlstein GR, Jain A, Strober W. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology 1999; 117:1078-88.
28. Stokkers PC, Hommes DW. New cytokine therapeutics for inflammatory bowel disease. Cytokine 2004; 28:167-73.
29. Tomita M, Ayabe T, Matsuzaki Y, Onitsuka T. Immunohistochemical analysis of nm23-H1 gene product in node-positive lung cancer and lymph nodes. Lung Cancer 1999; 24:11-6.
30. Kimura N, Shimada N, Fukuda M, Ishijima Y, Miyazaki H, Ishii A et al. Regulation of cellular functions by nucleoside diphosphate kinases in mammals. J Bioenerg Biomembr 2000; 32: 309-15.
31. Ishijima Y, Shimada N, Fukuda M, Miyazaki H, Orlov NY, Orlova TG et al. Overexpression of nucleoside diphosphate kinases induces neurite outgrowth and their substitution to inactive forms leads to suppression of nerve growth factor- and dibutyryl cyclic AMP-induced effects in PC12D cells. FEBS Lett 1999; 445: 155-9.
32. Miyazaki H, Fukuda M, Ishijima Y, Takagi, Y, Iimura T, Negishi A et al. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture. Clin Cancer Res 1999; 5: 4301-7.
33. Keim D, Hailat N, Melhem R, Zhu XX, Lascu I, Veron M et al. Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase. J Clin Invest 1992; 89: 919-24.
34. Firestein R, Feuerstein N. Association of activating transcription factor 2 (ATF2) with the ubiquitin-conjugating enzyme hUBC9. Implication of the ubiquitin/proteasome pathway in regulation of ATF2 in T cells. J Biol Chem 1998; 273: 5892-902.
35. Orian A, Whiteside S, Israel A, Stancovski I, Schwartz AL, Ciechanover A. Ubiquitin-mediated processing of NF-kappa B transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation. J Biol Chem 1995; 270: 21707-14.
36. Shibata F, Ito A, Ohkuma Y, Mitsui K. Mitogenic activity of S100A9 (MRP-14). Biol Pharm Bull 2005; 28: 2312-14.
37. Hobbs JA, May R, Tanousis K, McNeill E, Mathies M, Gebhardt C et al. Myeloid cell function in MRP-14 (S100A9) null mice. Mol Cell Biol 2003; 23: 2564-76.
38. Lominadze G, Rane MJ, Merchant M, Ca J, Ward RA, McLeish KR. Myeloid-related protein-14 is a p38 MAPK substrate in human neutrophils. J Immunol 2005; 174:7257-67.